AbbVie Inc (ABBV) is trading at $250.35 up 0.36% over the past 24 hours. Its Galaxy Score is 65.8, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 359.9K engagements and 254 posts with 57% positive social sentiment.
AI summary: AbbVie Inc. is a large-cap pharmaceutical company driven by immunology drugs like Rinvoq and Skyrizi. The stock is consolidating around $249–$251, driven by bullish immunology pipeline news counteracting bearish pressures from Humira erosion and leverage concerns.